farrokh dehdashti

Professor

Washington University in St. Louis

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Farrokh Dehdashti is a faculty member at Washington University in St. Louis, USA. His research focuses on advanced imaging techniques in oncology, particularly pertaining to FDG PET/CT and SPECT methodologies. He has contributed to multiple studies assessing diagnostic accuracy and treatment response in various malignancies, including prostate and cervical cancers. His work integrates innovative imaging approaches to enhance the understanding of cancer treatment efficacy and patient safety.

Articles (12)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

Washington University in St. Louis

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

farrokh dehdashti

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

A Projection-Domain Low-Count Quantitative SPECT Method for ɑ-Particle-Emitting Radiopharmaceutical Therapy

Diagnostic Accuracy of <sup>99m</sup>Tc-Sestamibi SPECT/CT for Characterization of Solid Renal Masses

First-in-Humans Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging

FDG PET/CT–based Response Assessment in Malignancies

18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy-Results from Multicenter ACRIN 6685 Clinical Trial

<sup>18</sup>F-FDG PET in Myocardial Viability Assessment: A Practical and Time-Efficient Protocol

An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women with Newly Diagnosed Locally Advanced Cervical Cancer

Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer

Coronary circulatory function with increasing obesity: A complex U-turn

Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 49, 2, (550-562), 10.1007/s00259-021-05489-8)

Detection of Additional Primary Neoplasms on <sup>18</sup>F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer

Pilot Study: PARP1 Imaging in Advanced Prostate Cancer

Collaborators (5)

David Ballard

Adeel Haq

Rathan M. Subramaniam

RICHARD L. WAHL

Kooresh Shoghi

Make your next move.